Nolan and his team are applying multiplexed technologies to achieve in-depth profiling of immune responses to SARS-CoV-2 in nonclinical and clinical studies. Their goal is to identify immune markers associated with outcomes for COVID-19 and understand the arrangement of immune cells relative to lung tissue cells during infection. Stanford Office of Technology Licensing info@otlmail.stanford.edu. 650-723-0651
Smart, interactive desk
Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the